Does vTv Therapeutics (VTVT) Have the Potential to Rally 25.17% as Wall Street Analysts Expect?

vTv Therapeutics (VTVT) closed the last trading session at $29.56, gaining 41.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $37 indicates a 25.2% upside potential.The average comprises three short-term price targets ranging from a low of $35.00 to a high of $40.00, with a standard deviation of $2.65. While the lowest estimate indicates an increase of 18.4% from the current pri ...